Leptospira Medium Base, Korthof

Leptospira Medium Base, Korthof 

To Order Contact us: lieven@wlsolutions.be

NBS Medium base 330mm

SHA1144 EACH
EUR 1328.1

NBS Innova 44 Medium Base 330mm

SHA1112 EACH
EUR 1377.12

Qual Set Base Cont Medium Range 1.0M to 3.0M

AQSB002 250ML
EUR 265.62

Tris-base

20-abx082498
  • EUR 393.60
  • EUR 243.60
  • EUR 493.20
  • 1 kg
  • 500 g
  • 5 kg

casting base

EHS3100-CAST ea
EUR 128.4

casting base

EHS3200-CAST ea
EUR 148.8

casting base

EHS3300-CAST ea
EUR 148.8

Tetracycline base

GA9779-100G 100 g
EUR 180

Tetracycline base

GA9779-10G 10 g
EUR 55.2

Tetracycline base

GA9779-25G 25 g
EUR 74.4

Rimonabant base

GX9120-10MG 10 mg
EUR 103.2

Rimonabant base

GX9120-25MG 25 mg
EUR 156

ProteoIQ Base

PS2 1
EUR 5114.4

Vincamine base

Q-1435.0005 5.0g
EUR 270
Description: Sum Formula: C21H26N2O3; CAS# [1617-90-9]

Vincamine base

Q-1435.0025 25.0g
EUR 963.6
Description: Sum Formula: C21H26N2O3; CAS# [1617-90-9]

Positioning Base

S44I041002 EACH
EUR 1409.04

Channel Base

C653 EACH
EUR 22.46

Leptospira antibody

10-1293 500 ug
EUR 571.2
Description: Mouse monoclonal Leptospira antibody

Mounting Medium

4300 3 ml
EUR 216.6
Description: This is Mounting medium (non-fading) used for maintaining optimal conditions needed to obtain the maximum fluorescence emission from Fluorescein.

DC MEDIUM

D04-117-10kg 10 kg
EUR 1894.8

DC MEDIUM

D04-117-2kg 2kg
EUR 458.4

DC MEDIUM

D04-117-500g 500 g
EUR 168

Advanced Medium

C0003-04 RT 500 mL Bottle
EUR 123.6

Medium 199

C0012-01 RT 500 mL Bottle
EUR 126

COLIFORM MEDIUM

C03-127-10kg 10 kg
EUR 1588.8

COLIFORM MEDIUM

C03-127-2kg 2kg
EUR 392.4

COLIFORM MEDIUM

C03-127-500g 500 g
EUR 150

Heller's Medium

CP014-010 10X1L
EUR 118.8

Heller's Medium

CP014-500 50L
EUR 151.2

Hoagland's Medium

CP015-010 10X1L
EUR 118.8

Hoagland's Medium

CP015-500 50L
EUR 151.2

A Medium

DJ1018 100g
EUR 101.76

EC MEDIUM

E05-100-10kg 10 kg
EUR 976.8

EC MEDIUM

E05-100-2Kg 2 Kg
EUR 259.2

EC MEDIUM

E05-100-500g 500 g
EUR 114

NeuroProgenitor Medium

NM42400 125 ml
EUR 364.8

HLP MEDIUM

H08-107-10kg 10 kg
EUR 2733.6

HLP MEDIUM

H08-107-2Kg 2 Kg
EUR 640.8

HLP MEDIUM

H08-107-500g 500 g
EUR 218.4

M9 Medium

SD7024 250g
EUR 86.1

M9CA Medium

SD7025 250g
EUR 86.1

YM Medium

SD7031 250g
EUR 84.54

TYGPN Medium

SD7032 250g
EUR 84.01

M63 Medium

SD7033 250g
EUR 86.1

SIM MEDIUM

S19-110-10kg 10 kg
EUR 1225.2

SIM MEDIUM

S19-110-2kg 2kg
EUR 313.2

SIM MEDIUM

S19-110-500g 500 g
EUR 128.4

SOB MEDIUM

S19-124-10kg 10 kg
EUR 1158

SOB MEDIUM

S19-124-2kg 2kg
EUR 298.8

SOB MEDIUM

S19-124-500g 500 g
EUR 124.8

TCBS Medium

MED1188 PK10
EUR 7.52

DNase Medium

MED1196 PK10
EUR 7.98

OF Medium

MED1664 500G
EUR 68.4

Vatalanib, Free Base

2026-25
EUR 366

Vatalanib, Free Base

2026-5
EUR 151.2

Erlotinib, Free Base

2048-100
EUR 189.6

Erlotinib, Free Base

2048-1000
EUR 464.4

Sunitinib, Free base

2097-100
EUR 229.2

Sunitinib, Free base

2097-1000
EUR 601.2

Sunitinib, Free base

2097-25
EUR 138

Ruxolitinib (free base)

10-042 25 mg
EUR 418.2
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19).

Lapatinib, Free base

2138-100
EUR 464.4

Lapatinib, Free base

2138-25
EUR 229.2

Ruxolitinib, Free base

2139-100 Ask for price

Ruxolitinib, Free base

2139-25
EUR 639.6

Ruxolitinib, Free base

2139-5
EUR 248.4

Imatinib, Free base

2141-100
EUR 176.4

Imatinib, Free base

2141-1000
EUR 502.8

Linsitinib, Free base

2294-25
EUR 679.2

Linsitinib, Free base

2294-5
EUR 222

Tipifarnib, Free base

2296-1
EUR 170.4

Tipifarnib, Free base

2296-5
EUR 496.8

Rucaparib (free base)

A8893-10 10 mg
EUR 240
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-200 200 mg
EUR 1243.2
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-5 5 mg
EUR 164.4
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-50 50 mg
EUR 547.2
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

LY2835219 free base

A3575-100 100 mg
EUR 686.4
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base

A3575-25 25 mg
EUR 309.6
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base

A3575-5 5 mg
EUR 170.4
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

R406 (free base)

A5880-100 100 mg
EUR 1452
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-25 25 mg
EUR 616.8
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5 5 mg
EUR 199.2
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5.1 10 mM (in 1mL DMSO)
EUR 316.8
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-S Evaluation Sample
EUR 97.2
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

THZ1 (Free base)

9664-25
EUR 1227.6

THZ1 (Free base)

9664-5
EUR 352.8

MCC950 (Free base)

B1031-1
EUR 183.6

MCC950 (Free base)

B1031-5
EUR 548.4

FIPI (free base)

B2372-25
EUR 757.2

FIPI (free base)

B2372-5
EUR 235.2

Terbinafine (Free base)

B2423-250
EUR 248.4

Terbinafine (Free base)

B2423-50
EUR 144

PLX5622 (free base)

B2965-25 25 mg
EUR 903.6

PLX5622 (free base)

B2965-5 5 mg
EUR 272.4

Apatinib (Free base)

B1613-25
EUR 496.8

Leptospira Medium Base, Korthof